To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC4610 | Sb2602 |
Novel selective mTOR inhibitor
More description
|
|
| DCC4609 | sb-258719 Hydrochloride |
Selective 5-HT7 receptor antagonist
More description
|
|
| DCC4608 | Sb-243213 Dihydrochloride |
Selective 5-HT2C_receptor>5-HT2C inverse agonist
More description
|
|
| DCC4607 | Sb-239272 |
Inhibitor of p38 MAPK
More description
|
|
| DCC4606 | Sb-226552 |
Potent and selective agonist for the human ß3-adrenoceptor
More description
|
|
| DCC4605 | Sb-220025 Trihydrochloride |
Potent, specific inhibitor of human p38 mitogen-activated protein (MAP) kinase
More description
|
|
| DCC4604 | Sb-209670 |
Dual ETA and ETB receptor antagonist
More description
|
|
| DCC4603 | Sb-203347 |
Selective, active-site-directed 14 kDa PLA2 inhibitor, totally inhibiting LT and PAF formation, while prostanoid formation was not altered
More description
|
|
| DCC4602 | Sb1617 |
Novel neuroprotective agent, suppressing abnormal tau protein aggregation
More description
|
|
| DCC4601 | Sb1495 |
Novel reversible covalent inhibitor of the cyclin-dependent kinase 5 (Cdk5)-mediated phosphorylation of PPARγ at Ser245, a key factor in the insulin-sensitizing effect of PPARγ-targeted drugs
More description
|
|
| DCC4600 | Sb1404 |
PPARγ covalent ligand
More description
|
|
| DCC4599 | Sazetidine-a Dihydrochloride |
Subtype-selective α4β2 nicotinic acetylcholine receptor partial agonist
More description
|
|
| DCC4598 | Saussureamine C |
Inhibitor of H274Y and N294S mutants
More description
|
|
| DCC4597 | Sat-in-3 |
Novel inhibitor of salmonella serine acetyltransferase (SAT), the enzyme that catalyzes the rate-limiting step of L-cysteine biosynthesis
More description
|
|
| DCC4596 | Satavaptan Fumarate |
Selective non-peptide vasopressin V2 receptor antagonist
More description
|
|
| DCC4595 | Satavaptan |
Selective non-peptide vasopressin V2 receptor antagonist
More description
|
|
| DCC4594 | Sars-cov-2 Nsp14/16 Inhibitor 2a |
Novel potent SARS-CoV-2 MTase Nsp14 and Nsp16 inhibitor
More description
|
|
| DCC4593 | Sars-cov-2 Nsp14 Mtase Inhibitor 16 |
Novel SARS-CoV-2 nsp14 Methyltransferase inhibitor
More description
|
|
| DCC4592 | Sars-cov-2 Mpro Inhibitor E24 |
Novel SARS-CoV-2 Main Protease (Mpro) Inhibitor, inhibiting viral replication with a nanomolar EC 50 value (844 nM) in SARS-CoV-2-infected Vero E6 cells, impairing SARS-CoV-2 replication in human lung epithelial cells and human-induced pluripotent stem ce
More description
|
|
| DCC4591 | Sars-cov 3clpro-in-7d |
Novel potent SARS-CoV-2 3CLpro inhibitor with IC 50 value of 73 nM
More description
|
|
| DCC4590 | Sarmustine |
Covalent Antineoplastic Agent
More description
|
|
| DCC4589 | Sard279 |
Novel Potent Selective Androgen Receptor Degrader (SARD)
More description
|
|
| DCC4588 | Sard033 |
Novel Highly Potent Selective Androgen Receptor Degrader (SARD)
More description
|
|
| DCC4587 | Sarcolipin Palmitoylated |
Regulator of the sarco-endoplasmic reticulum Ca -ATPase (SERCA1a), significantly slowing down the E2 to Ca2.E1 transition of SERCA1a while it affects neither phosphorylation nor dephosphorylation
More description
|
|
| DCC4586 | Sarcolipin |
Regulator of the sarco-endoplasmic reticulum Ca -ATPase (SERCA1a), significantly slowing down the E2 to Ca2.E1 transition of SERCA1a while it affects neither phosphorylation nor dephosphorylation
More description
|
|
| DCC4585 | Sarafloxacin |
Broad spectrum antibiotic
More description
|
|
| DCC4584 | Sar107375 |
Novel selective and potent dual inhibitor of thrombin and factor Xa
More description
|
|
| DCC4583 | Sar-104772 |
Novel inhibitor of TAFIa (activated thrombin-activatable fibrinolysis inhibitor)
More description
|
|
| DCC4582 | Saperconazole |
Broad-spectrum antifungal agent, selective inhibiting the cytochrome P-450-dependent ergosterol synthesis in Candida albicans, Aspergillus fumigatus and Trichophyton mentagrophytes, in vitro and in vivo activity against F. pedrosoi
More description
|
|
| DCC4581 | Sap2-in-23h |
Novel Potent Non-peptidic Inhibitor of Secreted Aspartic Protease 2 (SAP2) for the Treatment of Resistant Fungal Infections
More description
|
|